U.S. Markets open in 5 hrs 45 mins
  • S&P Futures

    3,401.25
    +7.75 (+0.23%)
     
  • Dow Futures

    27,646.00
    +65.00 (+0.24%)
     
  • Nasdaq Futures

    11,528.25
    +36.00 (+0.31%)
     
  • Russell 2000 Futures

    1,607.70
    +5.60 (+0.35%)
     
  • Crude Oil

    38.79
    +0.23 (+0.60%)
     
  • Gold

    1,907.20
    +1.50 (+0.08%)
     
  • Silver

    24.61
    +0.19 (+0.78%)
     
  • EUR/USD

    1.1826
    +0.0013 (+0.1064%)
     
  • 10-Yr Bond

    0.8010
    0.0000 (0.00%)
     
  • Vix

    32.05
    +4.50 (+16.33%)
     
  • GBP/USD

    1.3011
    -0.0010 (-0.0742%)
     
  • USD/JPY

    104.7970
    -0.0380 (-0.0362%)
     
  • BTC-USD

    13,130.91
    +28.71 (+0.22%)
     
  • CMC Crypto 200

    261.76
    -1.65 (-0.63%)
     
  • FTSE 100

    5,792.01
    -68.27 (-1.16%)
     
  • Nikkei 225

    23,485.80
    -8.54 (-0.04%)
     

Trillium (TRIL) Soars: Stock Adds 6% in Session

Zacks Equity Research
·2 mins read

Trillium Therapeutics Inc. TRIL was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company — as the stock is now up 70.2% in the past one-month time frame.

The company has seen one negative estimate revision in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Trillium currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

 

Trillium Therapeutics Inc. Price

Trillium Therapeutics Inc. Price
Trillium Therapeutics Inc. Price

Trillium Therapeutics Inc. price | Trillium Therapeutics Inc. Quote

 

A better-ranked stock in the Medical sector is Concert Pharmaceuticals Inc CNCE, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Concert Pharmaceuticals, Inc. (CNCE) : Free Stock Analysis Report
 
Trillium Therapeutics Inc. (TRIL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research